Showing results (41-50 of 418) with videos related to

Sort By:
Pageof 42
Frontiers in Immunology|October 29, 2020
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin MelanomaFrancesco Sabbatino, Giosuè Scognamiglio, Luigi Liguori, et al.
Lancet (London, England)|March 24, 2009
Monoclonal antibodies for cancer immunotherapyLouis M Weiner, Madhav V Dhodapkar, Soldano Ferrone
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodiesMichael Campoli, Robert Ferris, Soldano Ferrone, et al.
Human Immunology|November 7, 2003
Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanismsChien-Chung Chang, Shawn P Murphy, Soldano Ferrone
Seminars in Cancer Biology|September 11, 2007
Soluble HLA-G: Are they clinically relevant?Vito Pistoia, Fabio Morandi, Xinhui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Immune escape associated with functional defects in antigen-processing machinery in head and neck cancerRobert L Ferris, Theresa L Whiteside, Soldano Ferrone
Expert Opinion on Therapeutic Targets|July 21, 2015
Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumorsYangyang Wang, Claudia Geldres, Soldano Ferrone, et al.
Immunologic Research|October 20, 2005
Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significanceRobert L Ferris, Jennifer L Hunt, Soldano Ferrone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescapeRobert L Ferris, Elizabeth M Jaffee, Soldano Ferrone
Pageof 42